IVF/ICSI Outcomes of OCP Plus GnRH Agonist Protocol Versus OCP Plus GnRH Antagonist Fixed Protocol in Women With PCOS
Women with PCOS undergoing IVF/ICSI cycles will be evaluated by two different protocols. One
arm of the study includes oral contraceptive plus GnRH agonist protocol with 150 IU FSH
(standard dose) and second arm includes oral contraceptive plus GnRH Antagonist with 150 IU
FSH dose and fixed 6th day starting of GnRH Antagonist.
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Single Blind (Investigator)
Ongoing pregnancy rates
Ongoing pregnancy rates measured in OCP plus GnRH Agonist and OCP plus GnRH Antagonist cycles in women with PCOS
March 2009 to June 2011
Bulent Haydardedeoglu, M.D.
Turkey: Baskent University